Request for Covid-19 Impact Assessment of this Report
China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.
This report studies the Bronchiectasis Treatment development status and future trend in China, focuses on top players in China, also splits Bronchiectasis Treatment by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.
The major players in China market include
Alitair Pharmaceuticals Inc
Bayer AG
Chiesi Farmaceutici SpA
GlaxoSmithKline Plc
Grifols SA
Insmed Inc
Kamada Ltd
Polyphor Ltd
Recipharm AB
Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Amikacin Sulfate
ARD-3150
CHF-6333
Ciprofloxacin Hydrochloride
Doxofylline
Others
On the basis of the end users/application, this report covers
Clinic
Hospital
Homecare
If you have any special requirements, please let us know and we will offer you the report as you want.
China Bronchiectasis Treatment Market Research Report 2017
1 Bronchiectasis Treatment Overview
1.1 Product Overview and Scope of Bronchiectasis Treatment
1.2 Classification of Bronchiectasis Treatment by Product Category
1.2.1 China Bronchiectasis Treatment Sales (K Pcs) Comparison by Type (2012-2022)
1.2.2 China Bronchiectasis Treatment Sales (K Pcs) Market Share by Type in 2016
1.2.3 Amikacin Sulfate
1.2.4 ARD-3150
1.2.5 CHF-6333
1.2.6 Ciprofloxacin Hydrochloride
1.2.7 Doxofylline
1.2.8 Others
1.3 China Bronchiectasis Treatment Market by Application/End Users
1.3.1 China Bronchiectasis Treatment Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 China Bronchiectasis Treatment Market by Region
1.4.1 China Bronchiectasis Treatment Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Bronchiectasis Treatment Status and Prospect (2012-2022)
1.4.3 East China Bronchiectasis Treatment Status and Prospect (2012-2022)
1.4.4 Southwest China Bronchiectasis Treatment Status and Prospect (2012-2022)
1.4.5 Northeast China Bronchiectasis Treatment Status and Prospect (2012-2022)
1.4.6 North China Bronchiectasis Treatment Status and Prospect (2012-2022)
1.4.7 Central China Bronchiectasis Treatment Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Bronchiectasis Treatment (2012-2022)
1.5.1 China Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2022)
1.5.2 China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 China Bronchiectasis Treatment Market Competition by Players/Manufacturers
2.1 China Bronchiectasis Treatment Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Bronchiectasis Treatment Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Bronchiectasis Treatment Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Bronchiectasis Treatment Market Competitive Situation and Trends
2.4.1 China Bronchiectasis Treatment Market Concentration Rate
2.4.2 China Bronchiectasis Treatment Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Bronchiectasis Treatment Manufacturing Base Distribution, Sales Area, Product Types
3 China Bronchiectasis Treatment Sales and Revenue by Region (2012-2017)
3.1 China Bronchiectasis Treatment Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Bronchiectasis Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Bronchiectasis Treatment Price (USD/Pcs) by Regions (2012-2017)
4 China Bronchiectasis Treatment Sales and Revenue by Type/ Product Category (2012-2017)
4.1 China Bronchiectasis Treatment Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Bronchiectasis Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Bronchiectasis Treatment Price (USD/Pcs) by Type (2012-2017)
4.4 China Bronchiectasis Treatment Sales Growth Rate (%) by Type (2012-2017)
5 China Bronchiectasis Treatment Sales by Application (2012-2017)
5.1 China Bronchiectasis Treatment Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Bronchiectasis Treatment Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 China Bronchiectasis Treatment Players/Suppliers Profiles and Sales Data
6.1 Alitair Pharmaceuticals Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Bronchiectasis Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Alitair Pharmaceuticals Inc Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bayer AG
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Bronchiectasis Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bayer AG Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Chiesi Farmaceutici SpA
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Bronchiectasis Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Chiesi Farmaceutici SpA Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline Plc
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Bronchiectasis Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Plc Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Grifols SA
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Bronchiectasis Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Grifols SA Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Insmed Inc
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Bronchiectasis Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Insmed Inc Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Kamada Ltd
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Bronchiectasis Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Kamada Ltd Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Polyphor Ltd
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Bronchiectasis Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Polyphor Ltd Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
6.9 Recipharm AB
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Bronchiectasis Treatment Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Recipharm AB Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
6.9.4 Main Business/Business Overview
7 Bronchiectasis Treatment Manufacturing Cost Analysis
7.1 Bronchiectasis Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bronchiectasis Treatment
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Bronchiectasis Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bronchiectasis Treatment Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Bronchiectasis Treatment Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 China Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Bronchiectasis Treatment Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Bronchiectasis Treatment Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Bronchiectasis Treatment Sales (K Pcs) Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Bronchiectasis Treatment Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Bronchiectasis Treatment Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Bronchiectasis Treatment
Table China Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Bronchiectasis Treatment Sales Volume Market Share by Types in 2016
Figure Amikacin Sulfate Product Picture
Figure ARD-3150 Product Picture
Figure CHF-6333 Product Picture
Figure Ciprofloxacin Hydrochloride Product Picture
Figure Doxofylline Product Picture
Figure Others Product Picture
Figure China Bronchiectasis Treatment Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Bronchiectasis Treatment by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure South China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Bronchiectasis Treatment Sales of Key Players/Manufacturers (2012-2017)
Table China Bronchiectasis Treatment Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Bronchiectasis Treatment Sales Share (%) by Players/Manufacturers
Figure 2017 China Bronchiectasis Treatment Sales Share (%) by Players/Manufacturers
Table China Bronchiectasis Treatment Revenue by Players/Manufacturers (2012-2017)
Table China Bronchiectasis Treatment Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Bronchiectasis Treatment Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Bronchiectasis Treatment Revenue Market Share (%) by Players/Manufacturers
Table China Market Bronchiectasis Treatment Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Bronchiectasis Treatment Average Price of Key Players/Manufacturers in 2016
Figure China Bronchiectasis Treatment Market Share of Top 3 Players/Manufacturers
Figure China Bronchiectasis Treatment Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Bronchiectasis Treatment Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Bronchiectasis Treatment Product Category
Table China Bronchiectasis Treatment Sales (K Pcs) by Regions (2012-2017)
Table China Bronchiectasis Treatment Sales Share (%) by Regions (2012-2017)
Figure China Bronchiectasis Treatment Sales Share (%) by Regions (2012-2017)
Figure China Bronchiectasis Treatment Sales Market Share (%) by Regions in 2016
Table China Bronchiectasis Treatment Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Bronchiectasis Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Bronchiectasis Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Bronchiectasis Treatment Revenue Market Share (%) by Regions in 2016
Table China Bronchiectasis Treatment Price (USD/Pcs) by Regions (2012-2017)
Table China Bronchiectasis Treatment Sales (K Pcs) by Type (2012-2017)
Table China Bronchiectasis Treatment Sales Share (%) by Type (2012-2017)
Figure China Bronchiectasis Treatment Sales Share (%) by Type (2012-2017)
Figure China Bronchiectasis Treatment Sales Market Share (%) by Type in 2016
Table China Bronchiectasis Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Bronchiectasis Treatment Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Bronchiectasis Treatment by Type (2012-2017)
Figure Revenue Market Share of Bronchiectasis Treatment by Type in 2016
Table China Bronchiectasis Treatment Price (USD/Pcs) by Types (2012-2017)
Figure China Bronchiectasis Treatment Sales Growth Rate (%) by Type (2012-2017)
Table China Bronchiectasis Treatment Sales (K Pcs) by Applications (2012-2017)
Table China Bronchiectasis Treatment Sales Market Share (%) by Applications (2012-2017)
Figure China Bronchiectasis Treatment Sales Market Share (%) by Application (2012-2017)
Figure China Bronchiectasis Treatment Sales Market Share (%) by Application in 2016
Table China Bronchiectasis Treatment Sales Growth Rate (%) by Application (2012-2017)
Figure China Bronchiectasis Treatment Sales Growth Rate (%) by Application (2012-2017)
Table Alitair Pharmaceuticals Inc Bronchiectasis Treatment Basic Information List
Table Alitair Pharmaceuticals Inc Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Alitair Pharmaceuticals Inc Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Alitair Pharmaceuticals Inc Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Alitair Pharmaceuticals Inc Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Bayer AG Bronchiectasis Treatment Basic Information List
Table Bayer AG Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Bayer AG Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Bayer AG Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Bayer AG Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Chiesi Farmaceutici SpA Bronchiectasis Treatment Basic Information List
Table Chiesi Farmaceutici SpA Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Chiesi Farmaceutici SpA Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Chiesi Farmaceutici SpA Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Chiesi Farmaceutici SpA Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline Plc Bronchiectasis Treatment Basic Information List
Table GlaxoSmithKline Plc Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline Plc Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline Plc Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline Plc Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Grifols SA Bronchiectasis Treatment Basic Information List
Table Grifols SA Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Grifols SA Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Grifols SA Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Grifols SA Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Insmed Inc Bronchiectasis Treatment Basic Information List
Table Insmed Inc Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Insmed Inc Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Insmed Inc Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Insmed Inc Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Kamada Ltd Bronchiectasis Treatment Basic Information List
Table Kamada Ltd Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Kamada Ltd Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Kamada Ltd Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Kamada Ltd Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Polyphor Ltd Bronchiectasis Treatment Basic Information List
Table Polyphor Ltd Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Polyphor Ltd Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Polyphor Ltd Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Polyphor Ltd Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Recipharm AB Bronchiectasis Treatment Basic Information List
Table Recipharm AB Bronchiectasis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Recipharm AB Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Recipharm AB Bronchiectasis Treatment Sales Market Share (%) in China (2012-2017)
Figure Recipharm AB Bronchiectasis Treatment Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bronchiectasis Treatment
Figure Manufacturing Process Analysis of Bronchiectasis Treatment
Figure Bronchiectasis Treatment Industrial Chain Analysis
Table Raw Materials Sources of Bronchiectasis Treatment Major Players/Manufacturers in 2016
Table Major Buyers of Bronchiectasis Treatment
Table Distributors/Traders List
Figure China Bronchiectasis Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Bronchiectasis Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Bronchiectasis Treatment Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Bronchiectasis Treatment Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Bronchiectasis Treatment Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Bronchiectasis Treatment Sales Volume Market Share Forecast by Type in 2022
Table China Bronchiectasis Treatment Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Bronchiectasis Treatment Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Bronchiectasis Treatment Sales Volume Market Share Forecast by Application in 2022
Table China Bronchiectasis Treatment Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Bronchiectasis Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Bronchiectasis Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Bronchiectasis Treatment Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...